SurModics, Inc.
SRDX
$37.19
$1.103.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 120.80M | 121.58M | 125.45M | 126.08M | 120.82M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 120.80M | 121.58M | 125.45M | 126.08M | 120.82M |
| Cost of Revenue | 28.73M | 30.79M | 31.93M | 33.03M | 23.15M |
| Gross Profit | 92.07M | 90.78M | 93.52M | 93.05M | 97.67M |
| SG&A Expenses | 48.75M | 50.03M | 50.57M | 50.24M | 52.16M |
| Depreciation & Amortization | 3.51M | 3.47M | 3.49M | 3.50M | 3.49M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 119.35M | 122.65M | 124.35M | 125.12M | 125.40M |
| Operating Income | 1.45M | -1.07M | 1.10M | 955.00K | -4.58M |
| Income Before Tax | -14.69M | -14.57M | -9.73M | -7.51M | -9.16M |
| Income Tax Expenses | 2.94M | 5.29M | 4.68M | 4.04M | -7.76M |
| Earnings from Continuing Operations | -17.63 | -19.86 | -14.41 | -11.54 | -1.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.63M | -19.86M | -14.41M | -11.54M | -1.40M |
| EBIT | 1.45M | -1.07M | 1.10M | 955.00K | -4.58M |
| EBITDA | 9.92M | 7.41M | 9.54M | 9.65M | 4.13M |
| EPS Basic | -1.24 | -1.40 | -1.02 | -0.81 | -0.10 |
| Normalized Basic EPS | -0.04 | -0.14 | -0.04 | -0.04 | -0.28 |
| EPS Diluted | -1.25 | -1.41 | -1.03 | -0.83 | -0.10 |
| Normalized Diluted EPS | -0.04 | -0.14 | -0.04 | -0.04 | -0.28 |
| Average Basic Shares Outstanding | 56.98M | 56.87M | 56.74M | 56.61M | 56.49M |
| Average Diluted Shares Outstanding | 56.98M | 56.87M | 56.77M | 56.64M | 56.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |